Skip to main content

Table 1 Summary table of the main tumour results

From: Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implications

  Local recurrences Lymph node metastasis Bone metastasis p Local vs lymph node p Local vs bone p Lymph node vs Bone
T1/2eff (T1/2biol) (h) 8.8 ± 1.1 (28.7 ± 3.6) 10.2 ± 1.7 (51.8 ± 8.6) 9.0 ± 0.4 (30.9 ± 1.4) 0.003 0.9 0.4
SUVmean at 1 h 3.1 ± 1.1 5.2 ± 2.1 4.3 ± 0.9 < 0.001 0.003 0.8
SUVmax at 1 h 4.7 ± 2.4 6.8 ± 4.3 6.8 ± 2.9 0.02 0.03 0.5
τ (h) 1.1E-2 ± 2.4E-2 6.1E-3 ± 7.8E-3 6.4E-3 ± 1.0E-2 0.3 0.2 0.8
D/A (mGy/MBq) 3.71E-2 ± 1.87E-2 9.65E-2 ± 5.95E-2 5.40E-2 ± 3.86E-2 < 0.001 0.1 0.6
  1. Values are reported as mean ± standard deviation. Statistically significant differences (p < 0.05) are in bold